Literature DB >> 14677305

Bilateral total loss of vision following eclampsia--a case report.

M J Waziri-Erameh1, A E Omoti, O T Edema.   

Abstract

Visual loss following eclampsia is usually reported to be a result of retinopathy, exudative retinal detachment or cortical blindness. This paper reports the case of a 31-year-old para 5 + 0 housewife who developed bilateral visual loss following eclampsia and presented to the ophthalmologist four weeks later with a vision of light perception in both eyes. Examination showed evidence of hypertensive retinopathy. Convinced that the ocular findings were not responsible for such marked visual loss, she was commenced on systemic, topical and sub-conjunctival injection of steroids, acetazolamide and multivitamins. Her vision improved progressively to 6/6 right eye and 6/9 left eye after three weeks. Obstetricians are advised to refer cases of visual loss following eclampsia promptly to the ophthalmologist who should in turn manage aggressively with systemic, topical and sub-conjunctival steroids.

Entities:  

Mesh:

Year:  2003        PMID: 14677305

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  3 in total

1.  Postpartum amaurosis in a woman with severe preeclampsia.

Authors:  Mónica Mourelo; Miguel Alvarez; José L Díaz; Teresa García; Rita Galeiras; David Freire
Journal:  Indian J Crit Care Med       Date:  2011-10

2.  Postpartum Optic Neuropathy: Think of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Optic Neuritis - Report of Two Cases.

Authors:  Rohan R Mahale; Nibu Varghese; Pooja Mailankody; Hansashree Padmanabha; P S Mathuranath
Journal:  Ann Indian Acad Neurol       Date:  2020-07-22       Impact factor: 1.383

3.  Acute vision loss in post-partum period as presenting symptom of HIV-associated cryptococcal meningitis-an unusual case report.

Authors:  Aniruddha More; Ravindra Kumar Garg; Hardeep Singh Malhotra; Neeraj Kumar; Ravi Uniyal
Journal:  BMC Infect Dis       Date:  2016-10-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.